m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways

Xiaotian Han1,2, Lingfang Xia1,2, Yong Wu1,2

  • 1Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Oncogene
|January 15, 2025
PubMed

Insights

Newly identified circSTX6 is highly expressed in cervical cancer (CC), promoting tumor growth and metastasis. It stabilizes SPI1, activating the JAK2/STAT3 pathway, and forms a feedback loop with METTL3, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in various cancers.
  • The specific functions of many newly discovered circRNAs, including in cervical cancer (CC), require further elucidation.
  • Understanding novel circRNAs is crucial for advancing CC research and therapy.

Purpose of the Study:

  • To investigate the expression and oncogenic potential of a novel circRNA, circSTX6, in cervical cancer.
  • To elucidate the molecular mechanisms underlying circSTX6's function in CC progression.
  • To identify potential therapeutic targets for cervical cancer based on circSTX6's role.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess circSTX6 expression levels in CC tissues and cell lines.
  • Cell-based assays to evaluate the effects of circSTX6 on cell survival, proliferation, invasion, and migration.
  • Western blotting and luciferase reporter assays to investigate the interaction between circSTX6, SPI1, IL6, and the JAK2/STAT3 pathway.
  • RNA immunoprecipitation (RIP) and m6A RNA immunoprecipitation (m6A-RIP) assays to confirm molecular interactions and modifications.

Main Results:

  • circSTX6 expression is significantly upregulated in cervical cancer tissues and correlates with poor patient prognosis.
  • Overexpression of circSTX6 promotes cell survival, proliferation, invasion, and migration in CC cells.
  • circSTX6 enhances SPI1 stability, leading to increased IL6 transcription and activation of the JAK2/STAT3 signaling pathway.
  • METTL3-mediated m6A modification stabilizes circSTX6, which is recognized by YTHDC1, establishing a positive feedback loop involving METTL3, circSTX6, and SPI1.

Conclusions:

  • circSTX6 acts as an oncogenic circRNA in cervical cancer by promoting tumor progression through the SPI1/IL6/JAK2/STAT3 axis.
  • A positive feedback loop involving METTL3, circSTX6, and SPI1 contributes to the oncogenic functions of circSTX6.
  • circSTX6 represents a promising novel biomarker and therapeutic target for cervical cancer molecular therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K